Work

Abstract PS2-04-06: Real-world outcomes of trastuzumab deruxtecan with or without endocrine therapy in her2-low, hormone receptor-positive metastatic breast cancer: a propensity-matched analysis

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-04-06

Authors: M. Palleschi, A. Farolfi, C. Gianni, G. Miserocchi, M. Corianò, N. Gentili, M. Mariotti, G. Di Menna, O. Serra, C. Casadei, F. Rusconi, A. Andalò, S. Sabbioni, A. Carlini, D. Montanari, M. Sirico, R. Maltoni, L. Cecconetto, S. Sarti, F. Merloni, A. Musolino

Institutions: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, University of Parma, TriNetX (United States)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129512655

Cites:

Cited by:

Related to: